Supply of Nonchemotherapy Compounded Monoclonal Antibodies

Published

6 October 2025

Estimated value

£4,800,001

Place of performance

UKJ

Procedure

Open procedure

Lots

1

Notice number

062605-2025

Reference

ocds-h6vhtk-04a5f9

Official source

Official source

Description

Pharmacy Procurement Contract - Supply of Nonchemotherapy Compounded Monoclonal Antibodies. A Ranked Framework split into three LOTS LOT 1 - Infliximab Compounded Dose Banded Bags LOT 2 - Vedolizumab Compounded Bags LOT 3 - Natalizumab Compounded Bags The ranked framework will be open to participating Trusts of the South East Pharmacy Procurement Service.

Awards

Official publications

• FTS · 062605-2025 · 6 October 2025

Other tenders from Berkshire Healthcare NHS Foundation Trust

• Proactive Care (Berkshire West) - Frailty · 22 September 2026
• Ambient Voice Technology · 10 September 2026
• Medicine Dispensing Lockers - Provision & Support · 11 August 2026
• UoR Security Services · 4 August 2026
• Digital Musculoskeletal Triage and Management Service · 3 August 2026
• EBPOOH GP Cover Inpatient wards · 2 July 2026
• Mind in Berkshire Community Connector · 17 June 2026
• EFM BHFT 227075 - Outdoor Wetpour Resurfacing · 13 May 2026
• Compounded mAbs - Cancer Therapies · 12 May 2026
• Construction Information Service Building Supplement and CIS Core Online · 12 May 2026

See all →

Frequently asked questions

What is the estimated value of this tender?

The estimated value published by the buyer is £4,800,001.

Who is the buyer of this tender?

The contracting authority is Berkshire Healthcare NHS Foundation Trust (United Kingdom).

How can I bid for public tenders in the United Kingdom?

Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.